NCT07218120 In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy
| NCT ID | NCT07218120 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Memory Decline |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2025-06-09 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2025-06-09 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented in clinical research. This is true across a range of clinical areas but no more so than in Alzheimer's Disease Research. The purpose of this study is to assess whether offering small $25 financial incentives can increase enrollment of diverse community members to the Alzheimer's Prevention Trial (APT) Webstudy, a memory concerns registry meant to accelerate clinical trials, relative to non-monetary incentives such as a reusable grocery bag. To do this we will test in-person recruitment efforts at community events and locations, such as Northgate Gonzalez Market locations and local food bank events. We also aim to compare the relative cost of recruiting an additional person to the APT Webstudy.
Eligibility Criteria
Inclusion Criteria: * Adults aged 50 and over. * Able to read English or Spansih * Email access Exclusion Criteria: * Current dementia diagnosis.
Contact & Investigator
Mireille Jaocbson, PhD
PRINCIPAL INVESTIGATOR
University of Southern California
Frequently Asked Questions
Who can join the NCT07218120 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Memory Decline. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07218120 currently recruiting?
Yes, NCT07218120 is actively recruiting participants. Contact the research team at mireillj@usc.edu for enrollment information.
Where is the NCT07218120 trial being conducted?
This trial is being conducted at Chula Vista, United States.
Who is sponsoring the NCT07218120 clinical trial?
NCT07218120 is sponsored by University of Southern California. The principal investigator is Mireille Jaocbson, PhD at University of Southern California. The trial plans to enroll 400 participants.